Author Correction: Androgen receptor is a potential novel prognostic marker and oncogenic target in osteosarcoma with dependence on CDK11.

Sci Rep 2018 Aug 9;8(1):12107. Epub 2018 Aug 9.

Sarcoma Biology Laboratory, Department of Orthopaedic Surgery, Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Jackson 1115, Boston, Massachusetts, 02114, USA.

A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.

Download full-text PDF

Source
http://www.nature.com/articles/s41598-018-30644-x
Publisher Site
http://dx.doi.org/10.1038/s41598-018-30644-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6085288PMC
August 2018
18 Reads

Publication Analysis

Top Keywords

pdf versions
4
marker oncogenic
4
correction article
4
prognostic marker
4
oncogenic target
4
cdk11 correction
4
linked html
4
osteosarcoma dependence
4
html pdf
4
target osteosarcoma
4
versions paper
4
novel prognostic
4
error fixed
4
correction androgen
4
fixed paper
4
author correction
4
androgen receptor
4
article published
4
published linked
4
potential novel
4

Similar Publications